Aims and Scope
Scientia Pharmaceutica is a peer-reviewed open access scientific journal publishing original research papers, short communications and a limited number of reviews on all fields of pharmaceutical sciences and related areas, as well as on pharmaceutical practice. Since 2008 all articles are published open access.
Key Metrics
5.3
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
Q2
Pharmaceutical Science
SJR
- Q2 Pharmaceutical Science
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.45
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
2 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
85%
4 to 6 months
15%
7 to 9 months
0%
Above 9 months
0%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Curcumin
- Minimum inhibitory concentration
- Linear form
- Antibacterial activity
- Antimicrobial peptides
- Asenapine maleate
- Melatonin
- Essential oil
- Anti-inflammatory
- Bioavailability
- Quercetin
- Type 2 Diabetes Mellitus
- Zolmitriptan
- Piperine
- Propionibacterium acnes
- Detection limit
- Minimum bactericidal concentration
- Systematic review
Journal Specifications
| Overview | |
| Publisher | MDPI |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | CHF 1000 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Österreichische Apotheker-Verlagsgesellschaft m. b. H. |
| Frequency | Quarterly |
| Publication Start Year | 1930 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 6 |
| Article Processing Charges | CHF 1000 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
Planning to publish in Scientia Pharmaceutica ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Model Adequacy in Assessing the Predictive Performance of Regression Models in Pharmaceutical Product Optimization: The Bedaquiline Solid Lipid Nanoparticle Example
- 4 Dec 24
- Scientia Pharmaceutica
-
Full paper
New Approaches to Determining the D/H Ratio in Aqueous Media Based on Diffuse Laser Light Scattering for Promising Application in Deuterium-Depleted Water Analysis in Antitumor Therapy
- 2 Dec 24
- Scientia Pharmaceutica
-
Full paper
Resveratrol: Extraction Techniques, Bioactivity, and Therapeutic Potential in Ocular Diseases
- 14 Nov 24
- Scientia Pharmaceutica
-
Full paper
ChatGPT in Pharmacy Practice: Disruptive or Destructive Innovation? A Scoping Review
- 21 Oct 24
- Scientia Pharmaceutica
-
Full paper
Passiflora By-Products: Chemical Profile and Potential Use as Cosmetic Ingredients
- 18 Oct 24
- Scientia Pharmaceutica
-
Full paper
Evaluation of the Efficacy of Methylene Blue Administration in SARS-CoV-2-Affected Patients: A Proof-of-Concept Phase 2, Randomized, Placebo-Controlled, Single-Blind Clinical Trial
- 14 Oct 24
- Scientia Pharmaceutica
Scite analysis
Powered by scite_
1.5k articles received 10.6k citations see all
- 414 Supporting
- 9,883 Mentioning
- 38 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 1 Corrections
- 2 Errata
- 0 Expression of Concern
FAQs
How long has Scientia Pharmaceutica been actively publishing?
Scientia Pharmaceutica has been in operation since 1930 till date.
What is the publishing frequency of Scientia Pharmaceutica ?
Scientia Pharmaceutica published with a Quarterly frequency.
How many articles did Scientia Pharmaceutica publish last years ?
In 2023, Scientia Pharmaceutica published 56 articles.
What is the eISSN & pISSN for Scientia Pharmaceutica ?
For Scientia Pharmaceutica,eISSN is 2218-0532 and pISSN is0036-8709.
What is Citescore for Scientia Pharmaceutica ?
Citescore for Scientia Pharmaceutica is 5.3.
What is SNIP score for Scientia Pharmaceutica ?
SNIP score for Scientia Pharmaceutica is 1.45.
What is the SJR for Scientia Pharmaceutica ?
SJR for Scientia Pharmaceutica is Q2.
Who is the publisher of Scientia Pharmaceutica ?
MDPI is the publisher of Scientia Pharmaceutica.